Targeted drug delivery involves directing therapeutic agents specifically to cancer cells, sparing healthy tissues and reducing side effects. Nanoparticles can be functionalized with ligands or antibodies that bind to specific receptors on cancer cells, ensuring that the drugs are delivered precisely where they are needed.
